Journal Issue - Volume 26 Issue 5 (June 2009)
- New treatment options for glucose control in type 2 diabetes: an opportunity for individualised therapy is now possible
- Ken Shaw
- Published online on Jul 06, 2009
- DOI: 10.1002/pdi.1365 (p 174-175)
- The National Clinical Director for Diabetes: one year on
- Rowan Hillson
- Published online on Jul 06, 2009
- DOI: 10.1002/pdi.1366 (p 176-177)
- Treatment options for type 2 diabetes:introducing the incretin‐based therapies
- AH Barnett
- Published online on Jul 06, 2009
- DOI: 10.1002/pdi.1367 (p 179-183ii)
- The role of incretin‐based therapies in the management of type 2 diabetes
- D Russell‐Jones
- Published online on Jul 06, 2009
- DOI: 10.1002/pdi.1368 (p 186-188i)
- News
- Published online on Jul 06, 2009
- DOI: 10.1002/pdi.1369 (p 190-190)
- ABCD position statement on incretin mimetics and DPP‐4 inhibitors ‐2009
- CMB Edwards, PH Winocour
- Published online on Jul 06, 2009
- DOI: 10.1002/pdi.1370 (p 191-194)
- Quality of diabetes care in India, China, Brazil, Mexico and Russia
- ES Strock, RS Mazze
- Published online on Jul 06, 2009
- DOI: 10.1002/pdi.1371 (p 195-200i)
- Community diabetes consultants: the case for additional training
- Gillian Hawthorne, Waqar Malik, Felix Burden, Chris Walton, Jill Hill
- Published online on Jul 06, 2009
- DOI: 10.1002/pdi.1372 (p 202-202)
- Olanzapine‐induced hyperglycaemic, hyperchloraemic, hyperosmolar state
- Manjusha S Rathi, Michael W Mansfield
- Published online on Jul 06, 2009
- DOI: 10.1002/pdi.1373 (p 203-203)
- Gabapentin
- A MacEwan, G McKay, M Fisher
- Published online on Jul 06, 2009
- DOI: 10.1002/pdi.1374 (p 206-207)
Login/Logout
Journal Menu
- Home
- News
- Online Only
- Current Issue
- Archive Issues
- ABCD Position Statements
- CPD
- Supplements
- Useful Websites
Commercial Opportunities
Other Journals
.gif)
